Characterization of circulating tumor cells as a reflection of the tumor heterogeneity: myth or reality?

Abstract : The current main goal of diagnostic medicine is to detect crucial events in 'infinitely' small samples. The key question now is how to determine whether the rare cell events isolated and characterized from these samples reliably reflect the disease and heterogeneity of the tumor. In this review, we provide a short overview of the most recent methods developed for the isolation and characterization of rare cell events in clinical practice, with a specific focus on circulating tumor cells. We discuss the biological value to studying these cells at the single cell level and how these rare cell events can reflect tumor heterogeneity. The potential biomedical applications are also critically discussed in light of precision medicine.
Complete list of metadatas

https://www.hal.inserm.fr/inserm-01947472
Contributor : Dominique Heymann <>
Submitted on : Thursday, December 6, 2018 - 6:41:54 PM
Last modification on : Monday, May 20, 2019 - 3:32:01 PM
Long-term archiving on : Thursday, March 7, 2019 - 3:05:58 PM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : 2019-05-26

Please log in to resquest access to the document

Identifiers

Collections

Citation

Hannah Brown, Marta Tellez-Gabriel, Pierre-François Cartron, François Vallette, Marie-Françoise Heymann, et al.. Characterization of circulating tumor cells as a reflection of the tumor heterogeneity: myth or reality?. Drug Discovery Today Biosilico, Elsevier, 2018, Epub ahead of print. ⟨10.1016/j.drudis.2018.11.017⟩. ⟨inserm-01947472⟩

Share

Metrics

Record views

84